CapForce IBD 50 ETF
FFTY
50 hedge funds and large institutions have $25.7M invested in CapForce IBD 50 ETF in 2022 Q3 according to their latest regulatory filings, with 2 funds opening new positions, 12 increasing their positions, 19 reducing their positions, and 8 closing their positions.
0.62% less ownership
Funds ownership: 26.51% → 25.89% (-0.62%)
14% less funds holding
Funds holding: 58 → 50 (-8)
16% less capital invested
Capital invested by funds: $30.7M → $25.7M (-$4.99M)
37% less repeat investments, than reductions
Existing positions increased: 12 | Existing positions reduced: 19
75% less first-time investments, than exits
New positions opened: 2 | Existing positions closed: 8
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Royal Bank of Canada
Toronto,
Ontario, Canada
|
+$1.16M |
| 2 |
Goldman Sachs
New York
|
+$706K |
| 3 |
SFS
Sowell Financial Services
North Little Rock,
Arkansas
|
+$522K |
| 4 |
IWM
IHT Wealth Management
Chicago,
Illinois
|
+$360K |
| 5 |
TRCT
Tower Research Capital (TRC)
New York
|
+$167K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
RJA
Raymond James & Associates
St Petersburg,
Florida
|
-$914K |
| 2 |
CPIG
Chicago Partners Investment Group
Chicago,
Illinois
|
-$859K |
| 3 |
Citadel Advisors
Miami,
Florida
|
-$797K |
| 4 |
National Bank of Canada
Montreal,
Quebec, Canada
|
-$749K |
| 5 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$516K |
FFTY Hedge Fund Activity: Q3 2022 in Review
50 of the 5,805 institutional investors tracked by Wall St. Rank reported a position in CapForce IBD 50 ETF (FFTY) for Q3 2022, worth a combined $25.7M — down 16% from $30.7M a quarter earlier.
Sellers outnumbered buyers: 8 funds closed out of FFTY and 2 opened new positions — a net loss of 6 holders — while 19 trimmed existing stakes and 12 added.
The largest buyer was Royal Bank of Canada, adding an estimated $1.16M. The largest seller was Raymond James & Associates, cutting an estimated $914K.
- 50 institutional investors held CapForce IBD 50 ETF (FFTY) as of Q3 2022, down from 58 in Q2 2022.
- Funds reported $25.7M of CapForce IBD 50 ETF stock for Q3 2022, down 16% quarter-over-quarter.
- 2 funds opened new CapForce IBD 50 ETF positions in Q3 2022 and 8 closed out, a net change of -6 holders.
- The largest CapForce IBD 50 ETF buyer in Q3 2022 was Royal Bank of Canada, an estimated $1.16M added.
- The largest CapForce IBD 50 ETF seller in Q3 2022 was Raymond James & Associates, an estimated $914K sold.
Based on aggregated 13F filings for Q3 2022.